Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Feng Chi Biotech Corp. (6744) Income Statement

Feng Chi Biotech Corp. Income Statement

Last quarter (Q2 2026), Feng Chi Biotech Corp.'s total revenue was NT$75.67M, a decrease of 13.22% from the same quarter last year. In Q2, Feng Chi Biotech Corp.'s net income was NT$4.27M. See Feng Chi Biotech Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 177.36MNT$ 171.10MNT$ 180.58MNT$ 193.46MNT$ 182.57M
NT$ 79.16MNT$ 77.15MNT$ 79.60MNT$ 83.44MNT$ 86.11M
NT$ 65.31MNT$ 61.03MNT$ 56.56MNT$ 56.38MNT$ 59.66M
Depreciation and AmortizationNT$ 12.12MNT$ 9.22MNT$ 7.21MNT$ 6.31MNT$ 8.80M
NT$ 25.97MNT$ 29.80MNT$ 34.84MNT$ 36.79MNT$ 36.96M
NT$ 13.85MNT$ 16.12MNT$ 24.16MNT$ 27.07MNT$ 26.44M
NT$ 3.09MNT$ 4.21MNT$ 3.14MNT$ 3.35MNT$ 1.62M
NT$ 16.93MNT$ 20.33MNT$ 27.30MNT$ 30.42MNT$ 28.06M
NT$ 14.47MNT$ 16.59MNT$ 22.79MNT$ 24.61MNT$ 23.14M
Per Share Metrics
Basic EPSNT$ 0.94NT$ 1.08NT$ 1.48NT$ 1.60NT$ 1.50
Diluted EPSNT$ 0.94NT$ 1.07NT$ 1.47NT$ 1.60NT$ 1.50
Weighted Average Shares Outstanding15.40M15.40M15.40M15.38M15.40M
Weighted Average Shares Outstanding (Diluted)15.45M15.46M15.46M15.38M15.46M

Currency in TWD

Feng Chi Biotech Corp. Earnings and Revenue History

080M160M240M7.5 %10 %12.5 %15 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin